Cargando…

Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) account for over 80% of renal malignancies. The most common type of RCC can be classified into three subtypes including clear cell, papillary and chromophobe. ccRCC (the Clear Cell Renal Cell Carcinoma) is the most frequent form and shows variations in genetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Peng, Liu, Jia-Li, Pei, Shi-Mei, Wu, Chang-Peng, Yang, Kai, Wang, Shu-Peng, Wu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851245/
https://www.ncbi.nlm.nih.gov/pubmed/29534679
http://dx.doi.org/10.1186/s12885-018-4176-1
_version_ 1783306358684123136
author Wu, Peng
Liu, Jia-Li
Pei, Shi-Mei
Wu, Chang-Peng
Yang, Kai
Wang, Shu-Peng
Wu, Song
author_facet Wu, Peng
Liu, Jia-Li
Pei, Shi-Mei
Wu, Chang-Peng
Yang, Kai
Wang, Shu-Peng
Wu, Song
author_sort Wu, Peng
collection PubMed
description BACKGROUND: Renal cell carcinoma (RCC) account for over 80% of renal malignancies. The most common type of RCC can be classified into three subtypes including clear cell, papillary and chromophobe. ccRCC (the Clear Cell Renal Cell Carcinoma) is the most frequent form and shows variations in genetics and behavior. To improve accuracy and personalized care and increase the cure rate of cancer, molecular typing for individuals is necessary. METHODS: We adopted the genome, transcriptome and methylation HMK450 data of ccRCC in The Cancer Genome Atlas Network in this research. Consensus Clustering algorithm was used to cluster the expression data and three subtypes were found. To further validate our results, we analyzed an independent data set and arrived at a consistent conclusion. Next, we characterized the subtype by unifying genomic and clinical dimensions of ccRCC molecular stratification. We also implemented GSEA between the malignant subtype and the other subtypes to explore latent pathway varieties and WGCNA to discover intratumoral gene interaction network. Moreover, the epigenetic state changes between subgroups on methylation data are discovered and Kaplan-Meier survival analysis was performed to delve the relation between specific genes and prognosis. RESULTS: We found a subtype of poor prognosis in clear cell renal cell carcinoma, which is abnormally upregulated in focal adhesions and cytoskeleton related pathways, and the expression of core genes in the pathways are negatively correlated with patient outcomes. CONCLUSIONS: Our work of classification schema could provide an applicable framework of molecular typing to ccRCC patients which has implications to influence treatment decisions, judge biological mechanisms involved in ccRCC tumor progression, and potential future drug discovery. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4176-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5851245
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58512452018-03-21 Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma Wu, Peng Liu, Jia-Li Pei, Shi-Mei Wu, Chang-Peng Yang, Kai Wang, Shu-Peng Wu, Song BMC Cancer Research Article BACKGROUND: Renal cell carcinoma (RCC) account for over 80% of renal malignancies. The most common type of RCC can be classified into three subtypes including clear cell, papillary and chromophobe. ccRCC (the Clear Cell Renal Cell Carcinoma) is the most frequent form and shows variations in genetics and behavior. To improve accuracy and personalized care and increase the cure rate of cancer, molecular typing for individuals is necessary. METHODS: We adopted the genome, transcriptome and methylation HMK450 data of ccRCC in The Cancer Genome Atlas Network in this research. Consensus Clustering algorithm was used to cluster the expression data and three subtypes were found. To further validate our results, we analyzed an independent data set and arrived at a consistent conclusion. Next, we characterized the subtype by unifying genomic and clinical dimensions of ccRCC molecular stratification. We also implemented GSEA between the malignant subtype and the other subtypes to explore latent pathway varieties and WGCNA to discover intratumoral gene interaction network. Moreover, the epigenetic state changes between subgroups on methylation data are discovered and Kaplan-Meier survival analysis was performed to delve the relation between specific genes and prognosis. RESULTS: We found a subtype of poor prognosis in clear cell renal cell carcinoma, which is abnormally upregulated in focal adhesions and cytoskeleton related pathways, and the expression of core genes in the pathways are negatively correlated with patient outcomes. CONCLUSIONS: Our work of classification schema could provide an applicable framework of molecular typing to ccRCC patients which has implications to influence treatment decisions, judge biological mechanisms involved in ccRCC tumor progression, and potential future drug discovery. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4176-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-13 /pmc/articles/PMC5851245/ /pubmed/29534679 http://dx.doi.org/10.1186/s12885-018-4176-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wu, Peng
Liu, Jia-Li
Pei, Shi-Mei
Wu, Chang-Peng
Yang, Kai
Wang, Shu-Peng
Wu, Song
Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
title Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
title_full Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
title_fullStr Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
title_full_unstemmed Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
title_short Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
title_sort integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851245/
https://www.ncbi.nlm.nih.gov/pubmed/29534679
http://dx.doi.org/10.1186/s12885-018-4176-1
work_keys_str_mv AT wupeng integratedgenomicanalysisidentifiesclinicallyrelevantsubtypesofrenalclearcellcarcinoma
AT liujiali integratedgenomicanalysisidentifiesclinicallyrelevantsubtypesofrenalclearcellcarcinoma
AT peishimei integratedgenomicanalysisidentifiesclinicallyrelevantsubtypesofrenalclearcellcarcinoma
AT wuchangpeng integratedgenomicanalysisidentifiesclinicallyrelevantsubtypesofrenalclearcellcarcinoma
AT yangkai integratedgenomicanalysisidentifiesclinicallyrelevantsubtypesofrenalclearcellcarcinoma
AT wangshupeng integratedgenomicanalysisidentifiesclinicallyrelevantsubtypesofrenalclearcellcarcinoma
AT wusong integratedgenomicanalysisidentifiesclinicallyrelevantsubtypesofrenalclearcellcarcinoma